Portfolio Holdings Detail for ISIN IE00BFF5RX68
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Edge MSCI USA Value Factor UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker IUVD(USD) LSE
ETF Ticker IUVD.L(GBP) LSE

Holdings detail for RPRX

Stock Name	Royalty Pharma Plc
Ticker	RPRX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	GB00BMVP7Y09
LEI	549300FGFN7VOK8BZR03

Show aggregate RPRX holdings

News associated with RPRX

Royalty Pharma Expects At Least Mid-teens Average Annual Total Shareholder Return Over 2025-2030.: (RTTNews) - Royalty Pharma plc (RPRX) Thursday said it will host an Investor Day today, where senior executives will provide updates on the company's strategies aimed at driving shareholder value creation. - 2025-09-11 08:35:29
Maryland State Retirement & Pension System Trims Stock Position in Royalty Pharma PLC (NASDAQ:RPRX): Maryland State Retirement & Pension System lessened its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 18.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,291 shares of the biopharmaceutical company’s stock after selling 4,133 shares during the quarter. […] - 2025-08-15 05:22:58
PNC Financial Services Group Inc. Acquires 859 Shares of Royalty Pharma PLC (NASDAQ:RPRX): PNC Financial Services Group Inc. boosted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 7.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,665 shares of the biopharmaceutical company’s stock after purchasing an additional […] - 2025-08-15 04:48:59
Blair William & Co. IL Invests $212,000 in Royalty Pharma PLC (NASDAQ:RPRX): Blair William & Co. IL bought a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 6,801 shares of the biopharmaceutical company’s stock, valued at approximately $212,000. A number of other hedge […] - 2025-08-13 07:56:48
Deutsche Bank AG Sells 1,775,038 Shares of Royalty Pharma PLC (NASDAQ:RPRX): Deutsche Bank AG lessened its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 55.6% during the 1st quarter, Holdings Channel.com reports. The firm owned 1,414,926 shares of the biopharmaceutical company’s stock after selling 1,775,038 shares during the period. Deutsche Bank AG’s holdings in Royalty Pharma were worth $44,047,000 as of its most recent […] - 2025-08-13 05:54:50
Charles Schwab Investment Management Inc. Has $97.20 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX): Charles Schwab Investment Management Inc. cut its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 0.3% in the 1st quarter, Holdings Channel.com reports. The firm owned 3,122,531 shares of the biopharmaceutical company’s stock after selling 9,097 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Royalty Pharma were worth $97,204,000 as […] - 2025-08-13 05:10:46
Royalty Pharma (NASDAQ:RPRX) Raised to Buy at Wall Street Zen: Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. A number of other equities research analysts also recently weighed in on the company. Morgan Stanley boosted their target price on Royalty Pharma from $51.00 […] - 2025-08-11 03:50:55
Allianz Asset Management GmbH Has $6.03 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX): Allianz Asset Management GmbH reduced its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 64.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 193,591 shares of the biopharmaceutical company’s stock after selling 356,968 shares during the period. Allianz […] - 2025-07-28 07:00:47
Edgestream Partners L.P. Invests $659,000 in Royalty Pharma PLC (NASDAQ:RPRX): Edgestream Partners L.P. acquired a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 21,158 shares of the biopharmaceutical company’s stock, valued at approximately $659,000. Other hedge funds and other institutional investors also […] - 2025-07-20 05:24:59
Cerity Partners LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX): Cerity Partners LLC raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 786.3% during the 1st quarter, Holdings Channel reports. The fund owned 153,846 shares of the biopharmaceutical company’s stock after purchasing an additional 136,487 shares during the period. Cerity Partners LLC’s holdings in Royalty Pharma were worth $4,789,000 as […] - 2025-07-17 05:00:57
Xponance Inc. Acquires 1,437 Shares of Royalty Pharma PLC (NASDAQ:RPRX): Xponance Inc. raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 3.7% in the first quarter, HoldingsChannel.com reports. The firm owned 40,133 shares of the biopharmaceutical company’s stock after buying an additional 1,437 shares during the period. Xponance Inc.’s holdings in Royalty Pharma were worth $1,249,000 as of its most […] - 2025-07-16 05:48:56
M&T Bank Corp Buys 5,500 Shares of Royalty Pharma PLC (NASDAQ:RPRX): M&T Bank Corp raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 23.4% in the 1st quarter, Holdings Channel reports. The firm owned 28,967 shares of the biopharmaceutical company’s stock after acquiring an additional 5,500 shares during the period. M&T Bank Corp’s holdings in Royalty Pharma were worth $902,000 at […] - 2025-07-15 06:23:30
Teacher Retirement System of Texas Cuts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX): Teacher Retirement System of Texas cut its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 10.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,364 shares of the biopharmaceutical company’s stock after selling 12,028 shares during the […] - 2025-07-09 05:33:01
Allspring Global Investments Holdings LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX): Allspring Global Investments Holdings LLC boosted its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 4.0% in the first quarter, Holdings Channel.com reports. The institutional investor owned 561,724 shares of the biopharmaceutical company’s stock after acquiring an additional 21,729 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Royalty […] - 2025-07-03 06:09:03
11,210 Shares in Royalty Pharma PLC (NASDAQ:RPRX) Acquired by Kentucky Retirement Systems Insurance Trust Fund: Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, HoldingsChannel reports. The firm acquired 11,210 shares of the biopharmaceutical company’s stock, valued at approximately $349,000. Other hedge funds also recently bought and sold shares of the company. Louisbourg Investments Inc. […] - 2025-06-26 05:42:57
After Hours Most Active for Jun 24, 2025 : SNAP, NVDA, CMCSA, PLTR, INTC, SPR, AUR, RPRX, KVUE, MPW, GM, WMT: The NASDAQ 100 After Hours Indicator is down -.81 to 22,189.71. The total After hours volume is currently 173,627,396 shares traded.The following are the most active stocks for the after hours session: Snap Inc. (SNAP) is unchanged at $8.32, with 14,501,942 shares traded. SNAP's - 2025-06-24 17:24:56
Manning & Napier Advisors LLC Sells 44,505 Shares of Royalty Pharma PLC (NASDAQ:RPRX): Manning & Napier Advisors LLC lessened its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 54.9% during the first quarter, HoldingsChannel.com reports. The firm owned 36,549 shares of the biopharmaceutical company’s stock after selling 44,505 shares during the quarter. Manning & Napier Advisors LLC’s holdings in Royalty Pharma were worth $1,138,000 […] - 2025-06-24 05:20:57
After Hours Most Active for Jun 11, 2025 : PLTR, NVDA, AMZN, AAPL, RPRX, MCHPP: The NASDAQ 100 After Hours Indicator is up 14.32 to 21,875.12. The total After hours volume is currently 131,070,110 shares traded.The following are the most active stocks for the after hours session: Palantir Technologies Inc. (PLTR) is +0.25 at $136.64, with 5,538,416 shares t - 2025-06-11 17:24:56
Rhumbline Advisers Has $14.01 Million Position in Royalty Pharma plc (NASDAQ:RPRX): Rhumbline Advisers lowered its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The firm owned 449,964 shares of the biopharmaceutical company’s stock after selling 4,184 shares during the quarter. Rhumbline Advisers’ holdings in Royalty Pharma were worth $14,007,000 as of its most recent SEC […] - 2025-06-09 05:24:51
Lazard Asset Management LLC Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX): Lazard Asset Management LLC lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,457 shares of the biopharmaceutical company’s stock after selling 1,130 shares during the quarter. Lazard Asset […] - 2025-05-22 05:46:49
Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of “Buy” from Brokerages: Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received a consensus recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. […] - 2025-05-22 04:50:51
Captrust Financial Advisors Sells 14,499 Shares of Royalty Pharma plc (NASDAQ:RPRX): Captrust Financial Advisors reduced its position in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 49.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 14,829 shares of the biopharmaceutical company’s stock after selling 14,499 shares during the quarter. Captrust Financial Advisors’ holdings in Royalty Pharma were worth $378,000 as of […] - 2025-05-20 04:52:44
Analysts Predict 10% Gains Ahead For The Holdings of EUSA: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:59:43
Royalty Pharma (NASDAQ:RPRX) Raised to “Buy” at StockNews.com: Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday. Separately, Citigroup reiterated a “buy” rating on shares of Royalty Pharma in a research report on Friday, March 28th. One equities research analyst has rated […] - 2025-05-14 02:14:45
Stifel Financial Corp Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX): Stifel Financial Corp reduced its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 11.4% in the fourth quarter, Holdings Channel reports. The firm owned 17,152 shares of the biopharmaceutical company’s stock after selling 2,200 shares during the period. Stifel Financial Corp’s holdings in Royalty Pharma were worth $438,000 at the end […] - 2025-05-13 04:50:58
Prudential Financial Inc. Has $488,000 Stake in Royalty Pharma plc (NASDAQ:RPRX): Prudential Financial Inc. lowered its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 18,360 shares of the biopharmaceutical company’s stock after selling 955 shares during the period. Prudential Financial Inc.’s holdings in Royalty Pharma were worth $488,000 at the end of the […] - 2025-04-10 05:01:02
American Century Companies Inc. Boosts Holdings in Royalty Pharma plc (NASDAQ:RPRX): American Century Companies Inc. grew its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 67,160 shares of the biopharmaceutical company’s stock after buying an additional 3,671 shares […] - 2025-04-10 04:26:56
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by JPMorgan Chase & Co.: JPMorgan Chase & Co. lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 8.2% in the 4th quarter, Holdings Channel reports. The firm owned 1,395,242 shares of the biopharmaceutical company’s stock after purchasing an additional 105,824 shares during the quarter. JPMorgan Chase & Co.’s holdings in Royalty Pharma were worth $35,593,000 at […] - 2025-04-08 04:44:55
Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX): Schroder Investment Management Group lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 64.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 196,359 shares of the biopharmaceutical company’s stock after selling 354,483 shares during the quarter. Schroder Investment Management […] - 2025-04-06 05:29:08
Analysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $41.60: Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating […] - 2025-03-31 02:14:52

iShares Edge MSCI USA Value Factor UCITS ETF USD (Dist) RPRX holdings

Date	Number of RPRX Shares Held	Base Market Value of RPRX Shares	Local Market Value of RPRX Shares	Change in RPRX Shares Held	Change in RPRX Base Value	Current Price per RPRX Share Held	Previous Price per RPRX Share Held
2025-12-04 (Thursday)	161,967	USD 6,341,008	USD 6,341,008	2,210	USD 14,631	USD 39.15	USD 39.6
2025-12-03 (Wednesday)	159,757	USD 6,326,377	USD 6,326,377	0	USD 11,183	USD 39.6	USD 39.53
2025-12-02 (Tuesday)	159,757	USD 6,315,194	USD 6,315,194	338	USD -45,624	USD 39.53	USD 39.9
2025-12-01 (Monday)	159,419	USD 6,360,818	USD 6,360,818	169	USD -12,367	USD 39.9	USD 40.02
2025-11-28 (Friday)	159,250	USD 6,373,185	USD 6,373,185	0	USD 28,665	USD 40.02	USD 39.84
2025-11-27 (Thursday)	159,250	USD 6,344,520	USD 6,344,520	0	USD 0	USD 39.84	USD 39.84
2025-11-26 (Wednesday)	159,250	USD 6,344,520	USD 6,344,520	0	USD 47,775	USD 39.84	USD 39.54
2025-11-25 (Tuesday)	159,250	USD 6,296,745	USD 6,296,745	172	USD -26,606	USD 39.54	USD 39.75
2025-11-24 (Monday)	159,078	USD 6,323,351	USD 6,323,351	0	USD 132,035	USD 39.75	USD 38.92
2025-11-21 (Friday)	159,078	USD 6,191,316	USD 6,191,316	-358	USD 70,568	USD 38.92	USD 38.39
2025-11-20 (Thursday)	159,436	USD 6,120,748	USD 6,120,748	0	USD -41,453	USD 38.39	USD 38.65
2025-11-19 (Wednesday)	159,436	USD 6,162,201	USD 6,162,201	-179	USD -136,207	USD 38.65	USD 39.46
2025-11-18 (Tuesday)	159,615	USD 6,298,408	USD 6,298,408	895	USD 82,933	USD 39.46	USD 39.16
2025-11-17 (Monday)	158,720	USD 6,215,475	USD 6,215,475	2,366	USD 92,652	USD 39.16	USD 39.16

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RPRX by Blackrock for IE00BFF5RX68

Show aggregate share trades of RPRX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-04 BUY 2,210 39.150* 32.99
2025-12-02 BUY 338 39.530* 32.94
2025-12-01 BUY 169 40.500 39.600 39.690 USD 6,708 32.91
2025-11-25 BUY 172 40.000 39.270 39.343 USD 6,767 32.79
2025-11-21 SELL -358 38.920* 32.73 Profit of 11,719 on sale
2025-11-19 SELL -179 38.650* 32.68 Profit of 5,850 on sale
2025-11-18 BUY 895 39.460* 32.65
2025-11-17 BUY 2,366 39.495 38.965 39.018 USD 92,317 32.62
2025-11-14 BUY 2,197 39.645 38.820 38.902 USD 85,469 32.59
2025-11-10 BUY 1,859 39.399 38.510 38.599 USD 71,755 32.48
2025-11-07 BUY 845 38.560* 32.45
2025-11-04 BUY 676 38.080 36.755 36.888 USD 24,936 32.35
2025-11-03 BUY 169 37.715 37.130 37.189 USD 6,285 32.32
2025-10-23 BUY 716 36.850 37.160 37.129 USD 26,584 32.17
2025-10-22 SELL -716 36.840 37.690 37.605 USD -26,925 32.15 Loss of -3,909 on sale
2025-10-21 SELL -358 37.480 37.520 37.516 USD -13,431 32.12 Loss of -1,932 on sale
2025-10-20 BUY 179 36.630 36.920 36.891 USD 6,603 32.10
2025-10-17 BUY 358 37.010 37.130 37.118 USD 13,288 32.07
2025-10-16 SELL -537 36.340 36.450 36.439 USD -19,568 32.05 Loss of -2,355 on sale
2025-10-15 SELL -358 36.180 36.270 36.261 USD -12,981 32.03 Loss of -1,514 on sale
2025-10-07 BUY 531 36.100 36.480 36.442 USD 19,351 31.99
2025-10-06 SELL -716 36.130 36.220 36.211 USD -25,927 31.97 Loss of -3,035 on sale
2025-10-03 SELL -1,020 36.070 36.670 36.610 USD -37,342 31.95 Loss of -4,751 on sale
2025-10-02 BUY 507 36.490 36.600 36.589 USD 18,551 31.93
2025-10-01 SELL -507 36.320 36.455 36.442 USD -18,476 31.91 Loss of -2,299 on sale
2025-09-30 SELL -169 35.280 35.540 35.514 USD -6,002 31.89 Loss of -613 on sale
2025-09-29 SELL -169 35.250 35.290 35.286 USD -5,963 31.87 Loss of -577 on sale
2025-09-25 BUY 841 34.900 35.996 35.886 USD 30,180 31.84
2025-09-16 BUY 507 35.420 35.650 35.627 USD 18,063 31.78
2025-08-20 BUY 338 36.880 36.890 36.889 USD 12,468 31.71
2025-08-13 BUY 338 36.460 36.780 36.748 USD 12,421 31.63
2025-07-31 SELL -358 36.800 37.550 37.475 USD -13,416 31.52 Loss of -2,131 on sale
2025-07-30 SELL -537 37.120 37.500 37.462 USD -20,117 31.49 Loss of -3,207 on sale
2025-07-21 SELL -179 35.650 35.920 35.893 USD -6,425 31.35 Loss of -813 on sale
2025-07-18 SELL -179 35.590 35.650 35.644 USD -6,380 31.33 Loss of -773 on sale
2025-07-17 SELL -716 35.470 35.790 35.758 USD -25,603 31.30 Loss of -3,190 on sale
2025-07-16 SELL -1,790 35.600 36.890 36.761 USD -65,802 31.28 Loss of -9,815 on sale
2025-07-10 SELL -1,790 36.120 36.560 36.516 USD -65,364 31.16 Loss of -9,586 on sale
2025-07-08 SELL -1,611 35.510 35.910 35.870 USD -57,787 31.11 Loss of -7,675 on sale
2025-07-07 BUY 2,148 35.590 36.420 36.337 USD 78,052 31.08
2025-07-03 SELL -2,148 36.370 36.430 36.424 USD -78,239 31.01 Loss of -11,623 on sale
2025-06-30 SELL -716 36.030 36.220 36.201 USD -25,920 30.95 Loss of -3,760 on sale
2025-06-27 BUY 179 35.870 35.931 35.925 USD 6,431 30.92
2025-06-25 BUY 716 35.910 36.040 36.027 USD 25,795 30.86
2025-06-23 SELL -358 35.400 35.455 35.450 USD -12,691 30.80 Loss of -1,666 on sale
2025-06-18 SELL -1,611 34.910 34.990 34.982 USD -56,356 30.71 Loss of -6,875 on sale
2025-06-17 SELL -537 34.560 35.140 35.082 USD -18,839 30.69 Loss of -2,359 on sale
2025-06-13 BUY 179 34.840 35.380 35.326 USD 6,323 30.63
2025-06-11 BUY 2,327 34.050 34.180 34.167 USD 79,507 30.58
2025-06-04 BUY 516 33.440 33.715 33.688 USD 17,383 30.47
2025-06-03 SELL -172 33.290 33.540 33.515 USD -5,765 30.45 Loss of -527 on sale
2025-05-30 SELL -30,388 32.880 33.110 33.087 USD -1,005,448 30.41 Loss of -81,250 on sale
2025-05-29 SELL -201 32.640 32.770 32.757 USD -6,584 30.40 Loss of -474 on sale
2025-05-28 SELL -3,838 32.630 32.820 32.801 USD -125,890 30.38 Loss of -9,289 on sale
2025-05-27 SELL -7,272 32.690 32.810 32.798 USD -238,507 30.36 Loss of -17,701 on sale
2025-05-23 SELL -1,212 32.450 32.600 32.585 USD -39,493 30.33 Loss of -2,730 on sale
2025-05-22 SELL -812 32.310 32.930 32.868 USD -26,689 30.32 Loss of -2,071 on sale
2025-05-20 SELL -404 33.090 33.800 33.729 USD -13,627 30.28 Loss of -1,394 on sale
2025-05-19 SELL -201 34.250 34.315 34.308 USD -6,896 30.25 Loss of -816 on sale
2025-05-16 SELL -2,412 34.020 34.200 34.182 USD -82,447 30.22 Loss of -9,562 on sale
2025-05-15 BUY 3,015 33.120 33.130 33.129 USD 99,884 30.19
2025-05-14 BUY 603 32.290 33.110 33.028 USD 19,916 30.18
2025-05-12 BUY 2,412 33.350 33.600 33.575 USD 80,983 30.13
2025-05-09 BUY 402 33.150 33.720 33.663 USD 13,533 30.11
2025-05-08 BUY 603 33.100 34.110 34.009 USD 20,507 30.08
2025-05-07 BUY 603 32.750 32.825 32.818 USD 19,789 30.06
2025-05-06 BUY 201 32.110 33.040 32.947 USD 6,622 30.04
2025-05-02 BUY 204 32.890 32.970 32.962 USD 6,724 30.00
2025-04-30 BUY 612 32.820 33.000 32.982 USD 20,185 29.95
2025-04-25 SELL -203 32.200 32.300 32.290 USD -6,555 29.88 Loss of -488 on sale
2025-04-24 BUY 203 32.030 32.130 32.120 USD 6,520 29.86
2025-04-22 SELL -1,020 32.190 32.730 32.676 USD -33,330 29.83 Loss of -2,906 on sale
2025-04-15 BUY 812 32.450 32.505 32.500 USD 26,390 29.71
2025-04-14 BUY 407 32.290 32.320 32.317 USD 13,153 29.68
2025-04-11 SELL -203 31.950 32.005 32.000 USD -6,496 29.66 Loss of -475 on sale
2025-04-09 SELL -1,505 32.270 32.310 32.306 USD -48,621 29.62 Loss of -4,045 on sale
2025-04-08 SELL -2,408 30.850 31.600 31.525 USD -75,912 29.61 Loss of -4,620 on sale
2025-04-04 BUY 2,064 31.110 31.700 31.641 USD 65,307 29.58
2025-04-01 BUY 299 31.170 31.505 31.471 USD 9,410 29.54
2025-03-31 BUY 897 31.130 31.310 31.292 USD 28,069 29.53
2025-03-28 BUY 897 31.370 31.795 31.753 USD 28,482 29.51
2025-03-27 BUY 897 31.650 32.250 32.190 USD 28,874 29.48
2025-03-26 SELL -299 31.560 34.000 33.756 USD -10,093 29.46 Loss of -1,284 on sale
2025-03-24 BUY 1,806 33.750 33.990 33.966 USD 61,343 29.37
2025-03-21 BUY 574 33.700 33.840 33.826 USD 19,416 29.32
2025-03-20 BUY 4,816 33.500 33.510 33.509 USD 161,379 29.27
2025-03-19 BUY 3,913 33.410 33.500 33.491 USD 131,050 29.23
2025-03-18 BUY 301 33.410 33.600 33.581 USD 10,108 29.18
2025-03-17 SELL -286 33.020 33.265 33.240 USD -9,507 29.13 Loss of -1,175 on sale
2025-03-14 SELL -1,216 32.770 32.955 32.937 USD -40,051 29.09 Loss of -4,678 on sale
2025-03-11 BUY 3,344 32.460 32.770 32.739 USD 109,479 28.96
2025-03-05 BUY 301 33.770 33.790 33.788 USD 10,170 28.80
2025-02-28 BUY 4,939 33.640 33.730 33.721 USD 166,548 28.61
2025-02-27 BUY 296 33.370 33.620 33.595 USD 9,944 28.55
2025-02-26 BUY 592 33.380 33.870 33.821 USD 20,022 28.48
2025-02-25 BUY 296 33.690 34.115 34.073 USD 10,085 28.41
2025-02-24 BUY 1,192 33.800 34.200 34.160 USD 40,719 28.33
2025-02-21 SELL -10,513 33.420 33.670 33.645 USD -353,710 28.26 Loss of -56,589 on sale
2025-02-19 BUY 843 32.590 32.915 32.883 USD 27,720 28.13
2025-02-18 SELL -296 32.850 32.870 32.868 USD -9,729 28.06 Loss of -1,424 on sale
2025-02-12 BUY 19,012 32.340 32.560 32.538 USD 618,612 27.79
2025-02-10 SELL -294 31.720 31.790 31.783 USD -9,344 27.65 Loss of -1,215 on sale
2025-02-06 SELL -2,344 31.400 31.625 31.602 USD -74,076 27.52 Loss of -9,568 on sale
2025-02-04 BUY 2,960 31.260 31.600 31.566 USD 93,435 27.39
2025-02-03 BUY 296 31.330 31.660 31.627 USD 9,362 27.32
2025-01-31 SELL -592 31.580 31.678 31.668 USD -18,748 27.24 Loss of -2,620 on sale
2025-01-28 BUY 282 31.940 32.120 32.102 USD 9,053 26.98
2025-01-23 SELL -888 30.620 30.645 30.643 USD -27,211 26.73 Loss of -3,470 on sale
2025-01-02 SELL -2,623 25.790 25.890 25.880 USD -67,883 26.75 Profit of 2,292 on sale
2024-12-09 BUY 292 26.010 26.220 26.199 USD 7,650 26.79
2024-12-06 BUY 292 25.910 26.590 26.522 USD 7,744 26.81
2024-12-04 SELL -1,168 26.100 26.355 26.329 USD -30,753 26.84 Profit of 596 on sale
2024-11-29 SELL -2,044 26.660 26.660 26.660 USD -54,493 26.87 Profit of 421 on sale
2024-11-27 BUY 291 26.600 26.645 26.641 USD 7,752 26.88
2024-11-26 SELL -23 26.290 26.620 26.587 USD -612 26.91 Profit of 7 on sale
2024-11-26 SELL -23 26.290 26.620 26.587 USD -612 26.91 Profit of 7 on sale
2024-11-25 BUY 17,460 26.470 26.830 26.794 USD 467,823 26.92
2024-11-22 SELL -510 26.430 26.630 26.610 USD -13,571 26.94 Profit of 167 on sale
2024-11-20 SELL -255 26.220 26.290 26.283 USD -6,702 26.98 Profit of 177 on sale
2024-11-12 BUY 255 26.000 26.410 26.369 USD 6,724 27.12
2024-11-12 BUY 255 26.000 26.410 26.369 USD 6,724 27.12
2024-11-08 BUY 510 26.210 26.800 26.741 USD 13,638 27.18
2024-11-08 BUY 510 26.210 26.800 26.741 USD 13,638 27.18
2024-11-07 BUY 1,020 26.520 27.030 26.979 USD 27,519 27.24
2024-11-07 BUY 1,020 26.520 27.030 26.979 USD 27,519 27.24
2024-11-06 BUY 490 26.640 28.360 28.188 USD 13,812 27.26
2024-11-04 BUY 3,705 27.200 27.593 27.554 USD 102,086 27.24
2024-11-04 BUY 3,705 27.200 27.593 27.554 USD 102,086 27.24
2024-11-01 SELL -253 27.100 27.270 27.253 USD -6,895 27.26 Profit of 1 on sale
2024-11-01 SELL -253 27.100 27.270 27.253 USD -6,895 27.26 Profit of 1 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-04	BUY	2,210			39.150*		32.99
2025-12-02	BUY	338			39.530*		32.94
2025-12-01	BUY	169	40.500	39.600	39.690	USD 6,708	32.91
2025-11-25	BUY	172	40.000	39.270	39.343	USD 6,767	32.79
2025-11-21	SELL	-358			38.920*		32.73 Profit of 11,719 on sale
2025-11-19	SELL	-179			38.650*		32.68 Profit of 5,850 on sale
2025-11-18	BUY	895			39.460*		32.65
2025-11-17	BUY	2,366	39.495	38.965	39.018	USD 92,317	32.62
2025-11-14	BUY	2,197	39.645	38.820	38.902	USD 85,469	32.59
2025-11-10	BUY	1,859	39.399	38.510	38.599	USD 71,755	32.48
2025-11-07	BUY	845			38.560*		32.45
2025-11-04	BUY	676	38.080	36.755	36.888	USD 24,936	32.35
2025-11-03	BUY	169	37.715	37.130	37.189	USD 6,285	32.32
2025-10-23	BUY	716	36.850	37.160	37.129	USD 26,584	32.17
2025-10-22	SELL	-716	36.840	37.690	37.605	USD -26,925	32.15 Loss of -3,909 on sale
2025-10-21	SELL	-358	37.480	37.520	37.516	USD -13,431	32.12 Loss of -1,932 on sale
2025-10-20	BUY	179	36.630	36.920	36.891	USD 6,603	32.10
2025-10-17	BUY	358	37.010	37.130	37.118	USD 13,288	32.07
2025-10-16	SELL	-537	36.340	36.450	36.439	USD -19,568	32.05 Loss of -2,355 on sale
2025-10-15	SELL	-358	36.180	36.270	36.261	USD -12,981	32.03 Loss of -1,514 on sale
2025-10-07	BUY	531	36.100	36.480	36.442	USD 19,351	31.99
2025-10-06	SELL	-716	36.130	36.220	36.211	USD -25,927	31.97 Loss of -3,035 on sale
2025-10-03	SELL	-1,020	36.070	36.670	36.610	USD -37,342	31.95 Loss of -4,751 on sale
2025-10-02	BUY	507	36.490	36.600	36.589	USD 18,551	31.93
2025-10-01	SELL	-507	36.320	36.455	36.442	USD -18,476	31.91 Loss of -2,299 on sale
2025-09-30	SELL	-169	35.280	35.540	35.514	USD -6,002	31.89 Loss of -613 on sale
2025-09-29	SELL	-169	35.250	35.290	35.286	USD -5,963	31.87 Loss of -577 on sale
2025-09-25	BUY	841	34.900	35.996	35.886	USD 30,180	31.84
2025-09-16	BUY	507	35.420	35.650	35.627	USD 18,063	31.78
2025-08-20	BUY	338	36.880	36.890	36.889	USD 12,468	31.71
2025-08-13	BUY	338	36.460	36.780	36.748	USD 12,421	31.63
2025-07-31	SELL	-358	36.800	37.550	37.475	USD -13,416	31.52 Loss of -2,131 on sale
2025-07-30	SELL	-537	37.120	37.500	37.462	USD -20,117	31.49 Loss of -3,207 on sale
2025-07-21	SELL	-179	35.650	35.920	35.893	USD -6,425	31.35 Loss of -813 on sale
2025-07-18	SELL	-179	35.590	35.650	35.644	USD -6,380	31.33 Loss of -773 on sale
2025-07-17	SELL	-716	35.470	35.790	35.758	USD -25,603	31.30 Loss of -3,190 on sale
2025-07-16	SELL	-1,790	35.600	36.890	36.761	USD -65,802	31.28 Loss of -9,815 on sale
2025-07-10	SELL	-1,790	36.120	36.560	36.516	USD -65,364	31.16 Loss of -9,586 on sale
2025-07-08	SELL	-1,611	35.510	35.910	35.870	USD -57,787	31.11 Loss of -7,675 on sale
2025-07-07	BUY	2,148	35.590	36.420	36.337	USD 78,052	31.08
2025-07-03	SELL	-2,148	36.370	36.430	36.424	USD -78,239	31.01 Loss of -11,623 on sale
2025-06-30	SELL	-716	36.030	36.220	36.201	USD -25,920	30.95 Loss of -3,760 on sale
2025-06-27	BUY	179	35.870	35.931	35.925	USD 6,431	30.92
2025-06-25	BUY	716	35.910	36.040	36.027	USD 25,795	30.86
2025-06-23	SELL	-358	35.400	35.455	35.450	USD -12,691	30.80 Loss of -1,666 on sale
2025-06-18	SELL	-1,611	34.910	34.990	34.982	USD -56,356	30.71 Loss of -6,875 on sale
2025-06-17	SELL	-537	34.560	35.140	35.082	USD -18,839	30.69 Loss of -2,359 on sale
2025-06-13	BUY	179	34.840	35.380	35.326	USD 6,323	30.63
2025-06-11	BUY	2,327	34.050	34.180	34.167	USD 79,507	30.58
2025-06-04	BUY	516	33.440	33.715	33.688	USD 17,383	30.47
2025-06-03	SELL	-172	33.290	33.540	33.515	USD -5,765	30.45 Loss of -527 on sale
2025-05-30	SELL	-30,388	32.880	33.110	33.087	USD -1,005,448	30.41 Loss of -81,250 on sale
2025-05-29	SELL	-201	32.640	32.770	32.757	USD -6,584	30.40 Loss of -474 on sale
2025-05-28	SELL	-3,838	32.630	32.820	32.801	USD -125,890	30.38 Loss of -9,289 on sale
2025-05-27	SELL	-7,272	32.690	32.810	32.798	USD -238,507	30.36 Loss of -17,701 on sale
2025-05-23	SELL	-1,212	32.450	32.600	32.585	USD -39,493	30.33 Loss of -2,730 on sale
2025-05-22	SELL	-812	32.310	32.930	32.868	USD -26,689	30.32 Loss of -2,071 on sale
2025-05-20	SELL	-404	33.090	33.800	33.729	USD -13,627	30.28 Loss of -1,394 on sale
2025-05-19	SELL	-201	34.250	34.315	34.308	USD -6,896	30.25 Loss of -816 on sale
2025-05-16	SELL	-2,412	34.020	34.200	34.182	USD -82,447	30.22 Loss of -9,562 on sale
2025-05-15	BUY	3,015	33.120	33.130	33.129	USD 99,884	30.19
2025-05-14	BUY	603	32.290	33.110	33.028	USD 19,916	30.18
2025-05-12	BUY	2,412	33.350	33.600	33.575	USD 80,983	30.13
2025-05-09	BUY	402	33.150	33.720	33.663	USD 13,533	30.11
2025-05-08	BUY	603	33.100	34.110	34.009	USD 20,507	30.08
2025-05-07	BUY	603	32.750	32.825	32.818	USD 19,789	30.06
2025-05-06	BUY	201	32.110	33.040	32.947	USD 6,622	30.04
2025-05-02	BUY	204	32.890	32.970	32.962	USD 6,724	30.00
2025-04-30	BUY	612	32.820	33.000	32.982	USD 20,185	29.95
2025-04-25	SELL	-203	32.200	32.300	32.290	USD -6,555	29.88 Loss of -488 on sale
2025-04-24	BUY	203	32.030	32.130	32.120	USD 6,520	29.86
2025-04-22	SELL	-1,020	32.190	32.730	32.676	USD -33,330	29.83 Loss of -2,906 on sale
2025-04-15	BUY	812	32.450	32.505	32.500	USD 26,390	29.71
2025-04-14	BUY	407	32.290	32.320	32.317	USD 13,153	29.68
2025-04-11	SELL	-203	31.950	32.005	32.000	USD -6,496	29.66 Loss of -475 on sale
2025-04-09	SELL	-1,505	32.270	32.310	32.306	USD -48,621	29.62 Loss of -4,045 on sale
2025-04-08	SELL	-2,408	30.850	31.600	31.525	USD -75,912	29.61 Loss of -4,620 on sale
2025-04-04	BUY	2,064	31.110	31.700	31.641	USD 65,307	29.58
2025-04-01	BUY	299	31.170	31.505	31.471	USD 9,410	29.54
2025-03-31	BUY	897	31.130	31.310	31.292	USD 28,069	29.53
2025-03-28	BUY	897	31.370	31.795	31.753	USD 28,482	29.51
2025-03-27	BUY	897	31.650	32.250	32.190	USD 28,874	29.48
2025-03-26	SELL	-299	31.560	34.000	33.756	USD -10,093	29.46 Loss of -1,284 on sale
2025-03-24	BUY	1,806	33.750	33.990	33.966	USD 61,343	29.37
2025-03-21	BUY	574	33.700	33.840	33.826	USD 19,416	29.32
2025-03-20	BUY	4,816	33.500	33.510	33.509	USD 161,379	29.27
2025-03-19	BUY	3,913	33.410	33.500	33.491	USD 131,050	29.23
2025-03-18	BUY	301	33.410	33.600	33.581	USD 10,108	29.18
2025-03-17	SELL	-286	33.020	33.265	33.240	USD -9,507	29.13 Loss of -1,175 on sale
2025-03-14	SELL	-1,216	32.770	32.955	32.937	USD -40,051	29.09 Loss of -4,678 on sale
2025-03-11	BUY	3,344	32.460	32.770	32.739	USD 109,479	28.96
2025-03-05	BUY	301	33.770	33.790	33.788	USD 10,170	28.80
2025-02-28	BUY	4,939	33.640	33.730	33.721	USD 166,548	28.61
2025-02-27	BUY	296	33.370	33.620	33.595	USD 9,944	28.55
2025-02-26	BUY	592	33.380	33.870	33.821	USD 20,022	28.48
2025-02-25	BUY	296	33.690	34.115	34.073	USD 10,085	28.41
2025-02-24	BUY	1,192	33.800	34.200	34.160	USD 40,719	28.33
2025-02-21	SELL	-10,513	33.420	33.670	33.645	USD -353,710	28.26 Loss of -56,589 on sale
2025-02-19	BUY	843	32.590	32.915	32.883	USD 27,720	28.13
2025-02-18	SELL	-296	32.850	32.870	32.868	USD -9,729	28.06 Loss of -1,424 on sale
2025-02-12	BUY	19,012	32.340	32.560	32.538	USD 618,612	27.79
2025-02-10	SELL	-294	31.720	31.790	31.783	USD -9,344	27.65 Loss of -1,215 on sale
2025-02-06	SELL	-2,344	31.400	31.625	31.602	USD -74,076	27.52 Loss of -9,568 on sale
2025-02-04	BUY	2,960	31.260	31.600	31.566	USD 93,435	27.39
2025-02-03	BUY	296	31.330	31.660	31.627	USD 9,362	27.32
2025-01-31	SELL	-592	31.580	31.678	31.668	USD -18,748	27.24 Loss of -2,620 on sale
2025-01-28	BUY	282	31.940	32.120	32.102	USD 9,053	26.98
2025-01-23	SELL	-888	30.620	30.645	30.643	USD -27,211	26.73 Loss of -3,470 on sale
2025-01-02	SELL	-2,623	25.790	25.890	25.880	USD -67,883	26.75 Profit of 2,292 on sale
2024-12-09	BUY	292	26.010	26.220	26.199	USD 7,650	26.79
2024-12-06	BUY	292	25.910	26.590	26.522	USD 7,744	26.81
2024-12-04	SELL	-1,168	26.100	26.355	26.329	USD -30,753	26.84 Profit of 596 on sale
2024-11-29	SELL	-2,044	26.660	26.660	26.660	USD -54,493	26.87 Profit of 421 on sale
2024-11-27	BUY	291	26.600	26.645	26.641	USD 7,752	26.88
2024-11-26	SELL	-23	26.290	26.620	26.587	USD -612	26.91 Profit of 7 on sale
2024-11-26	SELL	-23	26.290	26.620	26.587	USD -612	26.91 Profit of 7 on sale
2024-11-25	BUY	17,460	26.470	26.830	26.794	USD 467,823	26.92
2024-11-22	SELL	-510	26.430	26.630	26.610	USD -13,571	26.94 Profit of 167 on sale
2024-11-20	SELL	-255	26.220	26.290	26.283	USD -6,702	26.98 Profit of 177 on sale
2024-11-12	BUY	255	26.000	26.410	26.369	USD 6,724	27.12
2024-11-12	BUY	255	26.000	26.410	26.369	USD 6,724	27.12
2024-11-08	BUY	510	26.210	26.800	26.741	USD 13,638	27.18
2024-11-08	BUY	510	26.210	26.800	26.741	USD 13,638	27.18
2024-11-07	BUY	1,020	26.520	27.030	26.979	USD 27,519	27.24
2024-11-07	BUY	1,020	26.520	27.030	26.979	USD 27,519	27.24
2024-11-06	BUY	490	26.640	28.360	28.188	USD 13,812	27.26
2024-11-04	BUY	3,705	27.200	27.593	27.554	USD 102,086	27.24
2024-11-04	BUY	3,705	27.200	27.593	27.554	USD 102,086	27.24
2024-11-01	SELL	-253	27.100	27.270	27.253	USD -6,895	27.26 Profit of 1 on sale
2024-11-01	SELL	-253	27.100	27.270	27.253	USD -6,895	27.26 Profit of 1 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RPRX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	877,435	0	1,269,348	69.1%
2025-09-18	854,156	255	1,225,709	69.7%
2025-09-17	890,428	0	1,130,889	78.7%
2025-09-16	849,691	0	1,371,042	62.0%
2025-09-15	1,310,051	875	1,800,476	72.8%
2025-09-12	1,066,120	800	1,339,292	79.6%
2025-09-11	1,220,120	283	1,532,656	79.6%
2025-09-10	1,195,119	790	1,440,333	83.0%
2025-09-09	1,259,853	924	1,521,804	82.8%
2025-09-08	1,967,280	1,094	3,312,547	59.4%
2025-09-05	2,792,926	0	4,789,487	58.3%
2025-09-04	649,497	0	1,396,642	46.5%
2025-09-03	741,511	0	3,964,244	18.7%
2025-09-02	1,164,461	621	1,836,122	63.4%
2025-08-29	568,848	644	1,099,441	51.7%
2025-08-28	343,443	1,229	665,672	51.6%
2025-08-27	718,529	15	1,134,797	63.3%
2025-08-26	376,806	3,158	782,116	48.2%
2025-08-25	523,360	0	1,666,116	31.4%
2025-08-22	416,975	1,403	983,556	42.4%
2025-08-21	515,906	1	789,605	65.3%
2025-08-20	668,934	557	1,359,619	49.2%
2025-08-19	282,363	1,211	801,139	35.2%
2025-08-18	470,777	713	735,143	64.0%
2025-08-15	370,886	0	849,955	43.6%
2025-08-14	437,271	0	1,270,825	34.4%
2025-08-13	450,930	0	2,187,219	20.6%
2025-08-12	378,708	321	1,366,736	27.7%
2025-08-11	566,603	322	1,321,771	42.9%
2025-08-08	732,304	1,141	1,058,552	69.2%
2025-08-07	637,779	141	1,478,119	43.1%
2025-08-06	968,026	95	1,335,306	72.5%
2025-08-05	817,147	97	1,153,956	70.8%
2025-08-04	562,562	677	830,964	67.7%
2025-08-01	356,771	847	641,246	55.6%
2025-07-31	550,713	210	657,912	83.7%
2025-07-30	529,655	432	816,351	64.9%
2025-07-29	600,859	25	752,372	79.9%
2025-07-28	682,728	1,073	824,975	82.8%
2025-07-25	351,993	50	514,201	68.5%
2025-07-24	396,410	57	557,229	71.1%
2025-07-23	289,217	2,996	787,220	36.7%
2025-07-22	460,421	0	666,171	69.1%
2025-07-21	489,845	1,682	693,054	70.7%
2025-07-18	355,376	0	587,434	60.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Edge MSCI USA Value Factor UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	IUVD(USD) LSE
ETF Ticker	IUVD.L(GBP) LSE